• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION Back to Search Results
Model Number ESS305
Device Problem Insufficient Information (3190)
Patient Problems Diarrhea (1811); Fatigue (1849); Memory Loss/Impairment (1958); Nausea (1970); Pain (1994); Myalgia (2238); Arthralgia (2355)
Event Type  Injury  
Event Description
This case was initially received via regulatory authority (b)(6) on 26-sep-2017.This spontaneous case was reported by a consumer and describes the occurrence of pelvic pain ("pelvic pain") and autoimmune hepatitis ("auto-immune hepatitis") in a female patient who had essure (batch no.C61996) inserted.The occurrence of additional non-serious events is detailed below.On (b)(6) 2015, the patient had essure inserted.On an unknown date, the patient experienced pelvic pain (seriousness criteria medically significant and intervention required), autoimmune hepatitis (seriousness criterion medically significant), fatigue ("fatigue"), myalgia ("muscular pain"), arthralgia ("joint pain"), nausea ("nausea"), abdominal pain upper ("stomach ache"), diarrhoea ("diarrhoea"), cardiac murmur ("heart murmur"), formication ("formication in arm, feet, buttock"), amnesia ("memory loss"), aphasia ("searching for words") and hyperhidrosis ("excessive sweats").The patient was treated with surgery (pending for surgery).At the time of the report, the pelvic pain, autoimmune hepatitis, fatigue, myalgia, arthralgia, nausea, abdominal pain upper, diarrhoea, cardiac murmur, formication, amnesia, aphasia and hyperhidrosis outcome was unknown.The reporter provided no causality assessment for abdominal pain upper, amnesia, aphasia, arthralgia, autoimmune hepatitis, cardiac murmur, diarrhoea, fatigue, formication, hyperhidrosis, myalgia, nausea and pelvic pain with essure.Diagnostic results: pending for allergy test on metal components of essure the list of similar cases contains essure reports received by bayer and older cases received by conceptus with similar events coded in meddra.In this particular case a search in the database was performed on 09-oct-2017 for the following meddra preferred term: pelvic pain- the analysis in the global safety database revealed 4.820 cases bayer is closely monitoring the benefit-risk profile of essure.A recent cumulative review of all available data on essure has not yielded any new safety signal with regard to this meddra pt.Quality-safety evaluation of ptc: unable to confirm complaint.Further company follow-up with the consumer or regulatory authority is not possible.Most recent follow-up information incorporated above includes: on 6-oct-2017: quality safety evaluation of ptc.Incident.At the time of reporting, there is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
INSERT, TUBAL OCCLUSION
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin 13353
GM   13353
Manufacturer Contact
k. lamberson
100 bayer blvd.
p.o. box 915
whippany 07981-0915
MDR Report Key6979103
MDR Text Key90298031
Report Number2951250-2017-05457
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Reporter Occupation Other
Type of Report Initial
Report Date 10/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2017
Device Model NumberESS305
Device Lot NumberC61996
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/26/2017
Initial Date FDA Received10/26/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-